» Articles » PMID: 37958337

Acceptability to Healthcare Professionals of Home-Based HPV Self-Sampling for Cervical Screening: A French Qualitative Study Conducted in an Area with Low Access to Health Services

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Nov 14
PMID 37958337
Authors
Affiliations
Soon will be listed here.
Abstract

Self-sampling may improve participation in cervical cancer secondary prevention programs by women who do not respond or respond irregularly when invited to contact a health professional for the collection of a cervical specimen. It could also help resolve access problems in areas with a low physician density. The present qualitative study examined barriers to screening, effective screening strategies, and the advantages and disadvantages of sending women urine or vaginal self-sampling kits in two medically underserved administrative departments in France (Mayenne and Sarthe) showing low cervical screening coverage. As part of the CapU4 randomized trial, a team of psychologists investigated the attitudes and experiences of 59 healthcare professionals (gynecologists, general practitioners, and midwives) through semi-structured interviews. Results indicated that health professionals believe that self-sampling may address the issues of low physician density and underscreening by removing logistical, organizational, financial, and psychological obstacles. They confirmed trust in the use of vaginal self-sampling, with urine self-sampling as an alternative solution (e.g., for women with vaginismus). The health professionals also identified several limitations of the self-sampling kit that will need to be addressed in future screening campaigns (incomplete kit, complex instructions, poor anatomical knowledge, and obesity).

References
1.
Arbyn M, Smith S, Temin S, Sultana F, Castle P . Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ. 2018; 363:k4823. PMC: 6278587. DOI: 10.1136/bmj.k4823. View

2.
Van Keer S, Latsuzbaia A, Broeck D, De Sutter P, Donders G, Doyen J . Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study. J Clin Virol. 2022; 155:105271. DOI: 10.1016/j.jcv.2022.105271. View

3.
John J, Halder A, Purwar S, Pushpalatha K, Gupta P, Dubey P . Study to determine efficacy of urinary HPV 16 & HPV 18 detection in predicting premalignant and malignant lesions of uterine cervix. Int J Gynaecol Obstet. 2022; 161(1):79-85. DOI: 10.1002/ijgo.14486. View

4.
Strelow B, OLaughlin D . Barriers to cervical cancer screening among immigrants. JAAPA. 2022; 35(3):23-27. DOI: 10.1097/01.JAA.0000819564.35151.0a. View

5.
Costa S, Verberckmoes B, Castle P, Arbyn M . Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening. Br J Cancer. 2022; 128(5):805-813. PMC: 9977737. DOI: 10.1038/s41416-022-02094-w. View